Brii Biosciences

Developer of biologics to treat hepatitis B infection

placeSan Francisco, California, United States calendar_todayFounded 2018 groups68 employees language briibio.com

Registered entities

Social engagement

Social engagement: 8.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Invesco, Yunfeng Capital, Arch Venture Partners, 6 Dimensions Capital.

Investor typeCountShare
Venture capital222%
Private equity444%
Other / undisclosed333%

Recent activity

27 May 2026
Milestone
regulatory
26 May 2026
Milestone
anniversary
20 May 2026
Event
EASL | The Home of Hepatology | 2026
Coming soon